Athos Therapeutics
Clinical-stage biotechnology company developing AI/ML-driven precision therapeutics for autoimmune and inflammatory diseases, with a focus on inflammatory bowel disease (IBD). The company integrates systems biology and human clinical/molecular datasets with computational medicinal chemistry and machine learning to identify disease-relevant targets, design small molecules, and advance candidates through preclinical and clinical development.
Industries
Nr. of Employees
small (1-50)
Athos Therapeutics
11301 W Olympic Blvd, Suite 592, Los Angeles, CA 90064 Laboratory: 1123 West Carson Street, Torrance, CA 90502 Athos Omics AI: 21250 Hawthorne Blvd, Suite 307, Torrance, CA 90503
Patents
Products
Pipeline of precision therapeutics for inflammatory diseases
A development pipeline focused on small-molecule precision therapeutics for inflammatory bowel disease and related inflammatory conditions.
Pipeline of precision therapeutics for inflammatory diseases
A development pipeline focused on small-molecule precision therapeutics for inflammatory bowel disease and related inflammatory conditions.
Services
A computational platform that integrates clinical and molecular data with machine learning and medicinal chemistry to identify targets and prioritize small-molecule candidates; offered via internal R&D and external partnerships.
A computational platform that integrates clinical and molecular data with machine learning and medicinal chemistry to identify targets and prioritize small-molecule candidates; offered via internal R&D and external partnerships.
Expertise Areas
- AI-driven drug discovery
- Precision therapeutics for autoimmune and inflammatory diseases
- Small-molecule medicinal chemistry
- Preclinical in vitro and in vivo modeling (IBD)
Key Technologies
- Machine learning / artificial intelligence
- Computational medicinal chemistry
- Systems biology
- Computational structural chemistry